Ensenyat–Mendez et al. construct a gene expression-based machine learning classifier to predict the response of triple-negative breast cancer to immune checkpoint inhibition combined with chemotherapy. Predictive performance of the 37-gene classifier is better than that of PD-1 or PD-L1.
- Miquel Ensenyat-Mendez
- Javier I. J. Orozco
- Diego M. Marzese
